NEW YORK (GenomeWeb) – Mass spec made progress toward the clinic this week as AB Sciex and Thermo Fisher Scientific released new US Food and Drug Administration-listed Class I instruments at the American Association for Clinical Chemistry annual meeting in Chicago.

Thermo Fisher announced the launch of a clinical LC-MS system consisting of its Prelude MD HPLC, Endura MD triple quadrupole, and ClinQuan MD software – the first LC-MS components the company has listed with FDA as Class I devices.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.